Efcacy and safety of two doses of FDC of Dapaglifozin, Sitagliptin and Metformin Immediate Release tablets in Type 2 Diabetes: A Phase 3 study

Category Primary study
Conference51st Annual Conference of Research Society for the Study of Diabetes in India, RSSDI 2023
Year 2023
This article has no abstract
Epistemonikos ID: e198e07cab41d806d763bea179e5fde1acae45e3
First added on: Apr 04, 2026